These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26861551)

  • 21. The discovery of BMS-457, a potent and selective CCR1 antagonist.
    Gardner DS; Santella JB; Duncia JV; Carter PH; Dhar TG; Wu H; Guo W; Cavallaro C; Van Kirk K; Yarde M; Briceno SW; Grafstrom RR; Liu R; Patel SR; Tebben AJ; Camac D; Khan J; Watson A; Yang G; Rose A; Foster WR; Cvijic ME; Davies P; Hynes J
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3833-40. PubMed ID: 23707259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validity of methods to predict the respiratory sensitizing potential of chemicals: A study with a piperidinyl chlorotriazine derivative that caused an outbreak of occupational asthma.
    Vanoirbeek JA; Mandervelt C; Cunningham AR; Hoet PH; Xu H; Vanhooren HM; Nemery B
    Toxicol Sci; 2003 Dec; 76(2):338-46. PubMed ID: 14514965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of action of inhibition of allergic immune responses by a novel antedrug TLR7 agonist.
    Matsui H; Tomizawa H; Eiho K; Kashiwazaki Y; Edwards S; Biffen M; Bell JP; Bahl A; Leishman AJ; Murray CM; Takaku H; Ueda Y
    J Immunol; 2012 Dec; 189(11):5194-205. PubMed ID: 23125414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Administration of a dual toll-like receptor 7 and toll-like receptor 8 agonist protects against influenza in rats.
    Hammerbeck DM; Burleson GR; Schuller CJ; Vasilakos JP; Tomai M; Egging E; Cochran FR; Woulfe S; Miller RL
    Antiviral Res; 2007 Jan; 73(1):1-11. PubMed ID: 16959331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Redirection of allergen-specific TH2 responses by a modified adenine through Toll-like receptor 7 interaction and IL-12/IFN release.
    Filì L; Ferri S; Guarna F; Sampognaro S; Manuelli C; Liotta F; Cosmi L; Matucci A; Vultaggio A; Annunziato F; Maggi E; Guarna A; Romagnani S; Parronchi P
    J Allergy Clin Immunol; 2006 Aug; 118(2):511-7. PubMed ID: 16890779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of a highly potent series of TLR7 agonists.
    Jones P; Pryde DC; Tran TD; Adam FM; Bish G; Calo F; Ciaramella G; Dixon R; Duckworth J; Fox DN; Hay DA; Hitchin J; Horscroft N; Howard M; Laxton C; Parkinson T; Parsons G; Proctor K; Smith MC; Smith N; Thomas A
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5939-43. PubMed ID: 21885277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with the TLR7 agonist R848 induces regulatory T-cell-mediated suppression of established asthma symptoms.
    Van LP; Bardel E; Gregoire S; Vanoirbeek J; Schneider E; Dy M; Thieblemont N
    Eur J Immunol; 2011 Jul; 41(7):1992-9. PubMed ID: 21480211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of 1-[9-(4-chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-yl]-4-ethylaminopiperidine-4-carboxylic acid amide hydrochloride (CP-945,598), a novel, potent, and selective cannabinoid type 1 receptor antagonist.
    Griffith DA; Hadcock JR; Black SC; Iredale PA; Carpino PA; DaSilva-Jardine P; Day R; DiBrino J; Dow RL; Landis MS; O'Connor RE; Scott DO
    J Med Chem; 2009 Jan; 52(2):234-7. PubMed ID: 19102698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonists.
    Kandimalla ER; Struthers M; Bett AJ; Wisniewski T; Dubey SA; Jiang W; Precopio M; Sun Z; Wang H; Lan T; Agrawal S; Casimiro DR
    Cell Immunol; 2011; 270(2):126-34. PubMed ID: 21570062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of (3R)-7-hydroxy-N-((1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)- 3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3,4-tetrahydro- 3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonist.
    Thomas JB; Atkinson RN; Vinson NA; Catanzaro JL; Perretta CL; Fix SE; Mascarella SW; Rothman RB; Xu H; Dersch CM; Cantrell BE; Zimmerman DM; Carroll FI
    J Med Chem; 2003 Jul; 46(14):3127-37. PubMed ID: 12825951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective treatment of experimental ragweed-induced asthma with STAT-6-IP, a topically delivered cell-penetrating peptide.
    Wang Y; Li Y; Shan J; Fixman E; McCusker C
    Clin Exp Allergy; 2011 Nov; 41(11):1622-30. PubMed ID: 22093011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intranasal IL-12 produces discreet pulmonary and systemic effects on allergic inflammation and airway reactivity.
    Matsuse H; Kong X; Hu J; Wolf SF; Lockey RF; Mohapatra SS
    Int Immunopharmacol; 2003 Apr; 3(4):457-68. PubMed ID: 12689651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacillus-derived poly-γ-glutamic acid attenuates allergic airway inflammation through a Toll-like receptor-4-dependent pathway in a murine model of asthma.
    Lee K; Kim SH; Yoon HJ; Paik DJ; Kim JM; Youn J
    Clin Exp Allergy; 2011 Aug; 41(8):1143-56. PubMed ID: 21672055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and optimization of pteridinone Toll-like receptor 7 (TLR7) agonists for the oral treatment of viral hepatitis.
    Roethle PA; McFadden RM; Yang H; Hrvatin P; Hui H; Graupe M; Gallagher B; Chao J; Hesselgesser J; Duatschek P; Zheng J; Lu B; Tumas DB; Perry J; Halcomb RL
    J Med Chem; 2013 Sep; 56(18):7324-33. PubMed ID: 23961878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regioisomerism-dependent TLR7 agonism and antagonism in an imidazoquinoline.
    Shukla NM; Kimbrell MR; Malladi SS; David SA
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2211-4. PubMed ID: 19285861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of novel SCD1 inhibitors: 5-alkyl-4,5-dihydro-3H-spiro[1,5-benzoxazepine-2,4'-piperidine] analogs.
    Uto Y; Ueno Y; Kiyotsuka Y; Miyazawa Y; Kurata H; Ogata T; Takagi T; Wakimoto S; Ohsumi J
    Eur J Med Chem; 2011 May; 46(5):1892-6. PubMed ID: 21356569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of TD-4306, a long-acting β2-agonist for the treatment of asthma and COPD.
    McKinnell RM; Klein U; Linsell MS; Moran EJ; Nodwell MB; Pfeiffer JW; Thomas GR; Yu C; Jacobsen JR
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2871-6. PubMed ID: 24835980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intratracheal and oral administration of SM-276001: a selective TLR7 agonist, leads to antitumor efficacy in primary and metastatic models of cancer.
    Koga-Yamakawa E; Dovedi SJ; Murata M; Matsui H; Leishman AJ; Bell J; Ferguson D; Heaton SP; Oki T; Tomizawa H; Bahl A; Takaku H; Wilkinson RW; Harada H
    Int J Cancer; 2013 Feb; 132(3):580-90. PubMed ID: 22733292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptor 7 selective synthetic oligoribonucleotide agonists: synthesis and structure-activity relationship studies.
    Lan T; Dai M; Wang D; Zhu FG; Kandimalla ER; Agrawal S
    J Med Chem; 2009 Nov; 52(21):6871-9. PubMed ID: 19824640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and optimisation of orally active TLR7 agonists for the treatment of hepatitis C virus infection.
    Tran TD; Pryde DC; Jones P; Adam FM; Benson N; Bish G; Calo F; Ciaramella G; Dixon R; Duckworth J; Fox DN; Hay DA; Hitchin J; Horscroft N; Howard M; Gardner I; Jones HM; Laxton C; Parkinson T; Parsons G; Proctor K; Smith MC; Smith N; Thomas A
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2389-93. PubMed ID: 21419626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.